Biocept (BIOC) Reports Q1 Loss of $0.41
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts BIOC Hot Sheet
Join SI Premium – FREE
Biocept (NASDAQ: BIOC) reported Q1 EPS of ($0.41), versus $0.00 reported last year. Revenue for the quarter came in at $700 thousand versus the consensus estimate of $1.58 million.
For earnings history and earnings-related data on Biocept (BIOC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CNA Financial (CNA) Misses Q3 EPS by 49c
- Check Point Software Technology (CHKP) Reports In-Line Q3 EPS
- Goldman Sachs Downgrades Floor & Decor Holdings (FND) to Sell
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
